Circulating Tumor Cells in Metastatic Breast Cancer: Clinical Applications and Future Possibilities
Circulating tumor cells (CTCs) have gained importance as an emerging biomarker in solid tumors in the last two decades. Several detection assays have been introduced by various study groups, with EpCAM-based CellSearch system being the most widely used and standardized technique. In breast cancer, d...
Main Authors: | Maggie Banys-Paluchowski, Florian Reinhardt, Tanja Fehm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/9/3311 |
Similar Items
-
A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells
by: André Franken, et al.
Published: (2020-05-01) -
Potential role of circulating tumor cell detection and monitoring in breast cancer: a review of current evidence
by: Malgorzata Banys-Paluchowski, et al.
Published: (2016-12-01) -
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
by: Claudia Koch, et al.
Published: (2020-09-01) -
HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
by: Cláudia Lopes, et al.
Published: (2021-09-01) -
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
by: Giulia Brisotto, et al.
Published: (2020-04-01)